<DOC>
	<DOC>NCT02825992</DOC>
	<brief_summary>Post Market Clinical Follow-up Study designed to evaluate the incidence of device- and procedure-related safety, efficacy, and efficiency (6 and 12 month outcomes) when using the AcQMap™ as an imaging and mapping system for ablation of persistent atrial fibrillation (AF).</brief_summary>
	<brief_title>Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation</brief_title>
	<detailed_description>A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Scheduled for an ablation of persistent atrial fibrillation Any duration of continuous AF lasting longer than 12 months Previous AF ablation Significant structural heart disease Previous cerebral infarct Major bleeding disorders Pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>